Skip to main content
Diabetes Therapy logoLink to Diabetes Therapy
. 2021 Jul 27;12(9):2625. doi: 10.1007/s13300-021-01119-6

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

Stefano Radellini 1, Enrica Vigneri 1, Valentina Guarnotta 1,, Felicia Panto 1, Carla Giordano 1,
PMCID: PMC8385013  PMID: 34313955

Correction to: Diabetes Ther (2021) 12:1677–1688 10.1007/s13300-021-01056-4

In the original article, the incorrect funding note has been published. The correct funding statement is “No funding or sponsorship was received for this study or publication of this article. Editorial support was provided by Edra S.p.A, and the rapid service fee was unconditionally funded by AstraZeneca.”

The original article has been updated.

Contributor Information

Valentina Guarnotta, Email: valentina.guarnotta@unipa.it.

Carla Giordano, Email: carla.giordano@unipa.it.


Articles from Diabetes Therapy are provided here courtesy of Springer

RESOURCES